Sort
85,873 grants matching “alzheimers”
Epidemiology of Functional Status in Elderly Hispanics
$837,139Mary N. Haan · University Of California, San Francisco · R01 · FY2012 · AG
Preclinical drug development of isoform selective JNK3 inhibitors for Alzheimer's disease.
$837,118Sung Ok Yoon · Ohio State University · R01 · FY2019 · AG
Preclinical drug development of isoform selective JNK3 inhibitors for Alzheimer's disease.
$837,118Sung Ok Yoon · Ohio State University · R01 · FY2020 · AG
Preclinical drug development of isoform selective JNK3 inhibitors for Alzheimer's disease.
$837,118Sung Ok Yoon · Ohio State University · R01 · FY2021 · AG
Air Pollution and Alzheimer's Dementia: Neuropathologic and Olfactory Mechanisms in Multi-Ethnic Longitudinal Cohorts
$837,013Jennifer Weuve · Boston University Medical Campus · R01 · FY2020 · AG
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences
$836,996David A Bennett · Rush University Medical Center · R01 · FY2011 · AG
Neural Correlates of Apathy Across the Alzheimer's Disease Continuum
$836,968Gad Asher Marshall · Massachusetts General Hospital · R01 · FY2021 · AG
GM-CSF/sargramostim treatment to improve cognition in Down syndrome
$836,914Huntington Potter · University Of Colorado Denver · R61 · FY2022 · AG
Transcriptional Control of Neuroinflammation in Alzheimer's Disease
$836,885Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AG
Core E: Biosample Core
$836,814Ho Wh Yu · University Of Pennsylvania · U19 · FY2023 · AG
Predictive Networks-based in-silico approach for Precision Medicine-repurposing for Alzheimer's Disease
$836,812Rui Chang · University Of Arizona · R56 · FY2019 · AG
Hypertension, Blood Pressure Targets, and Alzheimerâs Disease and Dementia Risk and Disparities among Nationally Representative US Veterans
$836,669Kristine Yaffe · University Of California, San Francisco · R01 · FY2024 · AG
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
$836,669Karen S. Quigley · Northeastern University · R01 · FY2021 · MH
Dallas Lifespan Brain Study-Wave 3: Neurodegeneration & Resilience in Cognition
$836,653Denise Cortis Park · University Of Texas Dallas · RF1 · FY2018 · AG
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease
$836,646Jasmeer P Chhatwal · Massachusetts General Hospital · R01 · FY2022 · AG
Research Program on Cognition and Neuromodulation Based Interventions (RP-CNBI)
$836,602Benjamin Michael Hampstead · University Of Michigan At Ann Arbor · R35 · FY2023 · AG
Progress Report for Neurotherapeutics Unit
$836,565Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Development of PET imaging probes for ROCK2
$836,532Zhengxin Cai · Yale University · R01 · FY2021 · AG
Revealing the roles of HSV1 lytic and latent transcripts in AD pathogenesis and therapy
$836,498Michael G Rosenfeld · University Of California, San Diego · R01 · FY2021 · AG
Functional characterization of Alzheimer's disease associated genetic variants
$836,490Yin Shen · University Of California, San Francisco · R01 · FY2019 · AG
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences
$836,451David A Bennett · Rush University Medical Center · R01 · FY2010 · AG
Telomere extension using nucleoside-modified mRNA and exosomes as a novel therape
$836,447Helen M Blau · Stanford University · R01 · FY2013 · AR
Risk Evaluation and Education for Alzheimer's Disease
$836,390Boston University Medical Campus · R01 · FY2003 · HG
Long-term Effects of Educational Investments on Cognitive Health
$836,257Tadeja Gracner · University Of Southern California · R01 · FY2025 · AG
CAMCI: Advancing the Use of Computerized Screening in Healthcare
$836,212Amy Eschman · Psychology Software Tools, Inc. · SB1 · FY2017 · AG